HomeFUNDING

FUNDING

Diality Closes $24 Million of Series B2 Financing

The Series B2 round of funding will be used for activities to support 510(k) clearance, preparing for the home clinical study and to build a U.S. commercial organization.

XRHealth Secures $10M in Funding

XRHealth, the gateway to the healthcare metaverse,  announced today that they raised $10M in funding to expand virtual healthcare treatment in the Metaverse. The funding was backed...

Gesund.ai Exits Stealth with $2M in Funding

Gesund’s superhighway of clinical-grade AI clears the way to safer, more effective tools to help improve medical outcomes for patients.

Supira Medical Closes $30M in an Oversubscribed Series C Financing

The funds will be used to finalize product development and initiate a first-in-human clinical study for the company's high-flow, low-profile percutaneous ventricular assist device (pVAD).

Lazurite Holdings Reports University Hospitals Ventures to Expand Collaboration with Lazurite™ & Invest in the Company

Lazurite Holdings had announced its collaboration with UH Ventures on a human factors study of the ArthroFree™ system in August.

9T Labs Raises $17M Series A Funding

9T Labs notes the investment will help fully commercialize the company’s Red Series® software tools, 3D printer, and molding equipment to lead the way in the production of sustainable high-performance parts for end-use applications.

EarliTec Dx Announces $19.5 Million Financing to Advance Autism Diagnosis and Treatment in Children as Young as 16 Months of Age

The EarliPoint® Evaluation for Autism Spectrum Disorder is an investigational device utilizing Dynamic Quantification of Social-Visual Engagement (DQSVE), to capture moment-by-moment looking behavior imperceptible to the human eye.

Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

Epitel, Inc., a digital health company developing a wearable, wireless EEG monitoring platform for seizure detection, announced today the closing of a $12.5 million...

Variantyx Secures $41.5M in Funding

“The funding is a great testament of confidence and trust in the company,” said Haim Neerman, CEO of Variantyx. “It allows us to expand our diagnostic solutions to a wider array of customers so that medical care can become more personalized. The growth of Variantyx has been exponential, and we look forward to sharing the new disruptive products we have in the pipeline.”
Exit mobile version